LOS ANGELES--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABBI) today announced that Thomas Silberg, president of APP Pharmaceuticals (formerly known as Abraxis Pharmaceutical Products), the company’s hospital-based business, will present a company overview at the Credit Suisse Healthcare Conference on Wednesday, November 14, 2007 at 4:00 p.m. PT at the Arizona Biltmore in Phoenix, AZ.
